Ownership history in Commodore Capital LP · 21 quarters on record
This page tracks every 13F SEC filing in which Commodore Capital LP reported a position in COGENT BIOSCIENCES INC (COGT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 2,196,845 | -5,053,155 | -69.7% | 5.19% | $78.0M | $35.52 |
| 2025 Q3 | ADDED | 7,250,000 | +4,938,836 | +213.7% | 5.08% | $104.1M | $14.36 |
| 2025 Q2 | REDUCED | 2,311,164 | -6,581,652 | -74.0% | 1.17% | $16.6M | $7.18 |
| 2025 Q1 | ADDED | 8,892,816 | +2,011,187 | +29.2% | 3.93% | $53.3M | $5.99 |
| 2024 Q4 | REDUCED | 6,881,629 | -658,301 | -8.7% | 3.93% | $53.7M | $7.80 |
| 2024 Q3 | REDUCED | 7,539,930 | -2,198,070 | -22.6% | 5.09% | $81.4M | $10.80 |
| 2024 Q2 | ADDED | 9,738,000 | +3,313,000 | +51.6% | 5.60% | $82.1M | $8.43 |
| 2024 Q1 | ADDED | 6,425,000 | +858,974 | +15.4% | 2.89% | $43.2M | $6.72 |
| 2023 Q4 | UNCHANGED | 5,566,026 | — | 0% | 2.83% | $32.7M | $5.88 |
| 2023 Q3 | UNCHANGED | 5,566,026 | — | 0% | 6.34% | $54.3M | $9.75 |
As of 2025 Q4 — sorted by position size